Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB04334"

Predicate	Value (sorted: default)
rdfs:label	"6-hydroxydopa quinone"
rdf:type	drugbank:drugs
drugbank:description	" experimental This compound belongs to the alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Alpha Amino Acids and Derivatives Organic Compounds Organic Acids and Derivatives Carboxylic Acids and Derivatives Amino Acids, Peptides, and Analogues p-Quinones p-Benzoquinones Amino Fatty Acids Polyols Polyamines Carboxylic Acids Enolates Enols Monoalkylamines quinone p-quinone p-benzoquinone ketone polyol polyamine carboxylic acid enolate enol organonitrogen compound amine primary amine primary aliphatic amine carbonyl group 2,4,5-trihydroxyphenylalanine quinone 5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone 5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone Topa quinone logP -2 ALOGPS logS -2 ALOGPS Water Solubility 2.01e+00 g/l ALOGPS logP -2.8 ChemAxon IUPAC Name (2S)-2-amino-3-(4-hydroxy-3,6-dioxocyclohexa-1,4-dien-1-yl)propanoic acid ChemAxon Traditional IUPAC Name 6-hydroxydopa quinone ChemAxon Molecular Weight 211.1715 ChemAxon Monoisotopic Weight 211.048072403 ChemAxon SMILES N[C@@H](CC1=CC(=O)C(O)=CC1=O)C(O)=O ChemAxon Molecular Formula C9H9NO5 ChemAxon InChI InChI=1S/C9H9NO5/c10-5(9(14)15)1-4-2-7(12)8(13)3-6(4)11/h2-3,5,13H,1,10H2,(H,14,15)/t5-/m0/s1 ChemAxon InChIKey InChIKey=AGMJSPIGDFKRRO-YFKPBYRVSA-N ChemAxon Polar Surface Area (PSA) 117.69 ChemAxon Refractivity 51.37 ChemAxon Polarizability 19.04 ChemAxon Rotatable Bond Count 3 ChemAxon H Bond Acceptor Count 6 ChemAxon H Bond Donor Count 3 ChemAxon pKa (strongest acidic) 1.73 ChemAxon pKa (strongest basic) 9.04 ChemAxon Physiological Charge 0 ChemAxon Number of Rings 1 ChemAxon Bioavailability 1 ChemAxon Rule of Five true ChemAxon ChEBI 36076 PubChem Compound 123871 PubChem Substance 46505126 ChemSpider 20059536 PDB TPQ BE0001002 Membrane primary amine oxidase Human # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 # Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10592235 unknown Membrane primary amine oxidase Secondary metabolites biosynthesis, transport and catabolism Cell adhesion protein that participates in lymphocyte recirculation by mediating the binding of lymphocytes to peripheral lymph node vascular endothelial cells in an L-selectin- independent fashion. Has a monoamine oxidase activity AOC3 17q21 Membrane; single-pass type II membrane protein 6-26 6.51 84623.0 Human HUGO Gene Nomenclature Committee (HGNC) HGNC:550 GenAtlas AOC3 GeneCards AOC3 GenBank Gene Database U39447 GenBank Protein Database 1399032 UniProtKB Q16853 UniProt Accession AOC3_HUMAN EC 1.4.3.6 HPAO Semicarbazide-sensitive amine oxidase SSAO VAP-1 Vascular adhesion protein 1 >Membrane copper amine oxidase MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQPWTHPGQSQLF ADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDRGSPPP AREALAIVFFGRQPQPNVSELVVGPLPHPSYMRDVTVERHGGPLPYHRRPVLFQEYLDID QMIFNRELPQASGLLHHCCFYKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFL HHVGLELLVNHKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGTGGSW SLKSPVPPGPAPPLQFYPQGPRFSVQGSRVASSLWTFSFGLGAFSGPRIFDVRFQGERLV YEISLQEALAIYGGNSPAAMTTRYVDGGFGMGKYTTPLTRGVDCPYLATYVDWHFLLESQ APKTIRDAFCVFEQNQGLPLRRHHSDLYSHYFGGLAETVLVVRSMSTLLNYDYVWDTVFH PSGAIEIRFYATGYISSAFLFGATGKYGNQVSEHTLGTVHTHSAHFKVDLDVAGLENWVW AEDMVFVPMAVPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHP RGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQNDPWAPTVDF SDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNGVGFFLRPYNFFDEDPSFYSA DSIYFRGDQDAGACEVNPLACLPQAAACAPDLPAFSHGGFSHN >2292 bp ATGAACCAGAAGACAATCCTCGTGCTCCTCATTCTGGCCGTCATCACCATCTTTGCCTTG GTTTGTGTCCTGCTGGTGGGCAGGGGTGGAGATGGGGGTGAACCCAGCCAGCTTCCCCAT TGCCCCTCTGTATCTCCCAGTGCCCAGCCTTGGACACACCCTGGCCAGAGCCAGCTGTTT GCAGACCTGAGCCGAGAGGAGCTGACGGCTGTGATGCGCTTTCTGACCCAGCGGCTGGGG CCAGGGCTGGTGGATGCAGCCCAGGCCCGGCCCTCGGACAACTGTGTCTTCTCAGTGGAG TTGCAGCTGCCTCCCAAGGCTGCAGCCCTGGCTCACTTGGACAGGGGGAGCCCCCCACCT GCCCGGGAGGCACTGGCCATCGTCTTCTTTGGCAGGCAACCCCAGCCCAACGTGAGTGAG CTGGTGGTGGGGCCACTGCCTCACCCCTCCTACATGCGGGACGTGACTGTGGAGCGTCAT GGAGGCCCCCTGCCCTATCACCGACGCCCCGTGCTGTTCCAAGAGTACCTGGACATAGAC CAGATGATCTTCAACAGAGAGCTGCCCCAGGCTTCTGGGCTTCTCCACCACTGTTGCTTC TACAAGCACCGGGGACGGAACCTGGTGACAATGACCACGGCTCCCCGTGGTCTGCAATCA GGGGACCGGGCCACCTGGTTTGGCCTCTACTACAACATCTCGGGCGCTGGGTTCTTCCTG CACCACGTGGGCTTGGAGCTGCTAGTGAACCACAAGGCCCTTGACCCTGCCCGCTGGACT ATCCAGAAGGTGTTCTATCAAGGCCGCTACTACGACAGCCTGGCCCAGCTGGAGGCCCAG TTTGAGGCCGGCCTGGTGAATGTGGTGCTGATCCCAGACAATGGCACAGGTGGGTCCTGG TCCCTGAAGTCCCCTGTGCCCCCGGGTCCAGCTCCCCCTCTACAGTTCTATCCCCAAGGC CCCCGCTTCAGTGTCCAGGGAAGTCGAGTGGCCTCCTCACTGTGGACTTTCTCCTTTGGC CTCGGAGCATTCAGTGGCCCAAGGATCTTTGACGTTCGCTTCCAAGGAGAAAGACTAGTT TATGAGATAAGCCTCCAAGAGGCCTTGGCCATCTATGGTGGAAATTCCCCAGCAGCAATG ACGACCCGCTATGTGGATGGAGGCTTTGGCATGGGCAAGTACACCACGCCCCTGACCCGT GGGGTGGACTGCCCCTACTTGGCCACCTACGTGGACTGGCACTTCCTTTTGGAGTCCCAG GCCCCCAAGACAATACGTGATGCCTTTTGTGTGTTTGAACAGAACCAGGGCCTCCCCCTG CGGCGACACCACTCAGATCTCTACTCGCACTACTTTGGGGGTCTTGCGGAAACGGTGCTG GTCGTCAGATCTATGTCCACCTTGCTCAACTATGACTATGTGTGGGATACGGTCTTCCAC CCCAGTGGGGCCATAGAAATACGATTCTATGCCACGGGCTACATCAGCTCGGCATTCCTC TTTGGTGCTACTGGGAAGTACGGGAACCAAGTGTCAGAGCACACCCTGGGCACGGTCCAC ACCCACAGCGCCCACTTCAAGGTGGATCTGGATGTAGCAGGACTGGAGAACTGGGTCTGG GCCGAGGATATGGTCTTTGTCCCCATGGCTGTGCCCTGGAGCCCTGAGCACCAGCTGCAG AGGCTGCAGGTGACCCGGAAGCTGCTGGAGATGGAGGAGCAGGCCGCCTTCCTCGTGGGA AGCGCCACCCCTCGCTACCTGTACCTGGCCAGCAACCACAGCAACAAGTGGGGTCACCCC CGGGGCTACCGCATCCAGATGCTCAGCTTTGCTGGAGAGCCGCTGCCCCAAAACAGCTCC ATGGCGAGAGGCTTCAGCTGGGAGAGGTACCAGCTGGCTGTGACCCAGCGGAAGGAGGAG GAGCCCAGTAGCAGCAGCGTTTTCAATCAGAATGACCCTTGGGCCCCCACTGTGGATTTC AGTGACTTCATCAACAATGAGACCATTGCTGGAAAGGATTTGGTGGCCTGGGTGACAGCT GGTTTTCTGCATATCCCACATGCAGAGGACATTCCTAACACAGTGACTGTGGGGAACGGC GTGGGCTTCTTCCTCCGACCCTATAACTTCTTTGACGAAGACCCCTCCTTCTACTCTGCC GACTCCATCTACTTCCGAGGGGACCAGGATGCTGGGGCCTGCGAGGTCAACCCCCTAGCT TGCCTGCCCCAGGCTGCTGCCTGTGCCCCCGACCTCCCTGCCTTCTCCCACGGGGGCTTC TCTCACAACTAG PF01179 Cu_amine_oxid PF02727 Cu_amine_oxidN2 PF02728 Cu_amine_oxidN3 function cation binding function transition metal ion binding function copper ion binding function binding function ion binding BE0001222 Primary amine oxidase Escherichia coli (strain K12) # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Primary amine oxidase Secondary metabolites biosynthesis, transport and catabolism The enzyme prefers aromatic over aliphatic amines tynA Periplasm None 5.71 84379.0 Escherichia coli (strain K12) GenBank Gene Database D23670 GenBank Protein Database 809499 UniProtKB P46883 UniProt Accession AMO_ECOLI 2- phenylethylamine oxidase Copper amine oxidase precursor EC 1.4.3.6 Tyramine oxidase >Copper amine oxidase precursor MGSPSLYSARKTTLALAVALSFAWQAPVFAHGGEAHMVPMDKTLKEFGADVQWDDYAQLF TLIKDGAYVKVKPGAQTAIVNGQPLALQVPVVMKDNKAWVSDTFINDVFQSGLDQTFQVE KRPHPLNALTADEIKQAVEIVKASADFKPNTRFTEISLLPPDKEAVWAFALENKPVDQPR KADVIMLDGKHIIEAVVDLQNNKLLSWQPIKDAHGMVLLDDFASVQNIINNSEEFAAAVK KRGITDAKKVITTPLTVGYFDGKDGLKQDARLLKVISYLDVGDGNYWAHPIENLVAVVDL EQKKIVKIEEGPVVPVPMTARPFDGRDRVAPAVKPMQIIEPEGKNYTITGDMIHWRNWDF HLSMNSRVGPMISTVTYNDNGTKRKVMYEGSLGGMIVPYGDPDIGWYFKAYLDSGDYGMG TLTSPIARGKDAPSNAVLLNETIADYTGVPMEIPRAIAVFERYAGPEYKHQEMGQPNVST ERRELVVRWISTVGNYDYIFDWIFHENGTIGIDAGATGIEAVKGVKAKTMHDETAKDDTR YGTLIDHNIVGTTHQHIYNFRLDLDVDGENNSLVAMDPVVKPNTAGGPRTSTMQVNQYNI GNEQDAAQKFDPGTIRLLSNPNKENRMGNPVSYQIIPYAGGTHPVAKGAQFAPDEWIYHR LSFMDKQLWVTRYHPGERFPEGKYPNRSTHDTGLGQYSKDNESLDNTDAVVWMTTGTTHV ARAEEWPIMPTEWVHTLLKPWNFFDETPTLGALKKDK >2274 bp ATGGGAAGCCCCTCTCTGTATTCTGCCCGTAAAACAACCCTGGCGTTGGCAGTCGCCTTA AGTTTCGCCTGGCAAGCGCCGGTATTTGCCCACGGTGGTGAAGCGCATATGGTGCCAATG GATAAAACGCTTAAAGAATTTGGTGCCGATGTGCAGTGGGACGACTACGCCCAGCTCTTT ACCCTGATTAAAGATGGCGCGTACGTGAAAGTGAAGCCTGGTGCGCAAACAGCAATTGTT AATGGTCAGCCTCTGGCACTGCAAGTACCGGTAGTGATGAAAGACAATAAAGCCTGGGTT TCTGACACCTTTATTAACGATGTTTTCCAGTCCGGGCTGGATCAAACTTTCCAGGTAGAA AAGCGCCCTCACCCACTTAATGCGCTAACTGCGGACGAAATTAAACAGGCCGTTGAAATT GTTAAAGCTTCCGCGGACTTCAAACCCAATACCCGTTTTACTGAGATCTCCCTGCTACCG CCAGATAAAGAAGCTGTCTGGGCGTTTGCGCTGGAAAACAAACCGGTTGACCAGCCGCGC AAAGCCGACGTCATTATGCTCGACGGCAAACATATCATCGAAGCGGTGGTGGATCTGCAA AACAACAAACTGCTCTCCTGGCAACCCATTAAAGACGCCCACGGTATGGTGTTGCTGGAT GATTTCGCCAGTGTGCAGAACATTATTAACAACAGTGAAGAATTTGCCGCTGCCGTGAAG AAACGCGGTATTACTGATGCCGAAAAAGTGATTACCACGCCGCTGACCGTAGTTATTTTC GATGGTAAAGATGGCCTGAAACAAGATGCCCGGTTGCTCAAAGTCATCATCAGCTATCTT GATGTCGGTGATGGCAACTACTGGCACATCATCGAAAACCTGGTGGCGGTCGTTGATTTA GAACAGAAAAAAATCGTTAAGATTGAAGAAGGTCCGGTAGTTCCGGTGCCAATGACCGCA CGCCCATTTGATGGCCGTGACCGCGTTGCTCCGGCAGTTAAGCCTATGCAAATCATTGAG CCTGAAGGTAAAAATTACACCATTACTGGCGATATGATTCACTGGCGGAACTGGGATTTT CACCTCAGCATGAACTCGCGCGTCGGGCCGATGATCTCCACCGTGACTTATAACGACAAT GGCACAAAACGCAAAGTCATGTACGAAGGTTCTCTCGGCGGCATGATTGTGCCTTACGGT GATCCTGATATTGGCTGGTACTTTAAAGCGTATCTGGACTCTGGTGACTACGGTATGGGC ACGCTAACCTCACCAATTGCTCGTGGTAAAGATGCCCCGTCTAACGCAGTGCTCCTTAAT GAAACCATCGCCGACTACACTGGCGTGCCGATGGAGATCCCTCGGCCTATCGCGGTATTT GAACGTTATGCCGGGCCGGAGTATAAGCATCAGGAAATGGGCCAGCCCAACGTCAGTACC GAACGCCGGGAGTTAGTGGTGCGCTGGATCAGTACAGTGGGTAACTATGACTACATTTTT GACTGGATCTTCCATGAAAACGGCACTATTGGCATCGATGCCGGTGCTACGGGCATCGAA GCGGTGAAAGGTGTTAAAGCGAAAACCATGCACGATGAGACGGCGAAAGATGACACGCGC TACGGCACGCTTATCGATCACAATATCGTGGGTACTACACACCAACATATTTATAATTTC CGCCTCGATCTGGATGTAGATGGCGAGAATAACAGCCTGGTGGCGATGGACCCAGTGGTA AAACCGAATACTGCCGGTGGCCCACGCACCAGTACCATGCAAGTTAATCAGTACAACATC GGCAATGAACAGGATGCCGCACAGAAATTTGATCCGGGCACGATTCGTCTGTTGAGTAAC CCGAACAAAGAGAACCGCATGGGCAATCCGGTTTCCTATCAAATTATTCCTTATGCAGGT GGTACTCACCCGGTAGCAAAAGGTGCCCAGTTCGCGCCGGACGAGTGGATCTATGATCGT TTAAGCTTTATGGACAAGCAGCTCTGGGTAACGCGTTATCATCCTGGCGAGCGTTTCCCG GAAGGCAAATATCCGAACCGTTCTACTCATGACACCGGTCTTGGACAATACAGTAAGGAT AACGAGTCGCTGGACAACACCGACGCCGTTGTCTGGATGACCACCGGCACCACACATGTG GCCCGCGCCGAAGAGTGGCCGATTATGCCGACCGAATGGGTACATACTCTGCTGAAACCA TGGAACTTCTTTGACGAAACGCCAACGCTAGGGGCGCTGAAGAAAGATAAGTGA PF01179 Cu_amine_oxid PF02727 Cu_amine_oxidN2 PF02728 Cu_amine_oxidN3 PF07833 Cu_amine_oxidN1 function binding function ion binding function cation binding function transition metal ion binding function copper ion binding BE0001831 Phenylethylamine oxidase Arthrobacter globiformis # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Phenylethylamine oxidase Secondary metabolites biosynthesis, transport and catabolism RCH(2)NH(2) + H(2)O + O(2) = RCHO + NH(3) + H(2)O(2) None 4.81 70647.0 Arthrobacter globiformis UniProtKB P46881 UniProt Accession PAOX_ARTGO Amine oxidase EC 1.4.3.6 Phenylethylamine oxidase precursor >Phenylethylamine oxidase precursor MTPSTIQTASPFRLASAGEISEVQGILRTAGLLGPEKRIAYLGVLDPARGAGSEAEDRRF RVFIHDVSGARPQEVTVSVTNGTVISAVELDTAATGELPVLEEEFEVVEQLLATDERWLK ALAARNLDVSKVRVAPLSAGVFEYAEERGRRILRGLAFVQDFPEDSAWAHPVDGLVAYVD VVSKEVTRVIDTGVFPVPAEHGNYTDPELTGPLRTTQKPISITQPEGPSFTVTGGNHIEW EKWSLDVGFDVREGVVLHNIAFRDGDRLRPIINRASIAEMVVPYGDPSPIRSWQNYFDTG EYLVGQYANSLELGCDCLGDITYLSPVISDAFGNPREIRNGICMHEEDWGILAKHSDLWS GINYTRRNRRMVISFFTTIGNYDYGFYWYLYLDGTIEFEAKATGVVFTSAFPEGGSDNIS QLAPGLGAPFHQHIFSARLDMAIDGFTNRVEEEDVVRQTMGPGNERGNAFSRKRTVLTRE SEAVREADARTGRTWIISNPESKNRLNEPVGYKLHAHNQPTLLADPGSSIARRAAFATKD LWVTRYADDERYPTGDFVNQHSGGAGLPSYIAQDRDIDGQDIVVWHTFGLTHFPRVEDWP IMPVDTVGFKLRPEGFFDRSPVLDVPANPSQSGSHCHG >1917 bp ATGACGCCCTCCACTATCCAAACAGCCAGCCCCTTCCGCCTTGCCTCAGCTGGGGAAATC AGTGAGGTGCAGGGCATTCTTCGGACCGCGGGCCTCCTTGGCCCGGAGAAGCGCATTGCC TACCTGGGCGTCCTTGACCCGGCCCGCGGCGCCGGCAGTGAAGCGGAAGACCGGCGCTTC CGGGTTTTCATCCACGACGTCTCCGGCGCCCGGCCCCAGGAAGTCACTGTCTCGGTCACC AACGGCACTGTGATCTCCGCCGTCGAACTCGATACCGCGGCCACCGGCGAACTGCCGGTC CTGGAAGAGGAGTTCGAGGTTGTGGAGCAACTGCTGGCCACCGACGAACGGTGGCTGAAG GCCCTGGCCGCCCGGAACCTTGACGTCAGCAAGGTGCGCGTTGCTCCGCTGTCCGCGGGT GTCTTCGAGTATGCGGAGGAGAGGGGCCGCCGGATCCTCCGCGGGCTTGCCTTCGTACAG GATTTTCCGGAGGACAGCGCTTGGGCTCATCCGGTTGACGGGCTGGTGGCCTACGTGGAC GTGGTCAGCAAGGAAGTCACCCGGGTGATCGACACCGGCGTCTTCCCCGTCCCGGCAGAG CACGGCAATTACACCGATCCCGAACTCACGGGTCCACTCCGCACCACCCAGAAACCCATC AGCATCACCCAGCCCGAAGGCCCCAGCTTCACGGTGACCGGCGGCAACCACATCGAATGG GAAAAATGGAGCCTGGACGTCGGCTTTGACGTCCGCGAGGGCGTGGTGCTGCACAACATT GCCTTCCGGGACGGGGACCGGCTCCGGCCCATCATCAACCGCGCGTCGATCGCCGAGATG GTGGTGCCGTACGGCGATCCGTCCCCGATCAGGTCCTGGCAGAACTACTTCGACACGGGG GAGTACCTGGTGGGCCAGTACGCCAACTCCCTCGAACTGGGCTGCGACTGCCTCGGCGAC ATCACCTACCTCAGCCCGGTCATCAGCGACGCCTTCGGCAACCCCCGCGAGATCCGCAAC GGCATCTGCATGCACGAGGAGGACTGGGGCATCCTGGCCAAGCACAGCGACCTTTGGTCC GGCATCAACTACACCCGCCGGAACCGCCGCATGGTGATCTCCTTCTTCACCACTATCGGC AACTACGACTACGGCTTCTACTGGTACCTCTACCTCGACGGCACCATCGAATTCGAAGCG AAAGCCACCGGCGTCGTCTTCACGTCCGCATTCCCGGAAGGCGGCTCGGACAACATTTCC CAGCTGGCACCGGGCCTGGGAGCGCCGTTCCACCAGCACATCTTCAGCGCCCGCCTGGAC ATGGCCATCGACGGCTTCACCAACAGGGTGGAGGAAGAGGACGTGGTCCGGCAAACCATG GGCCCGGGCAACGAGCGCGGCAACGCGTTCTCCCGAAAGCGCACCGTGCTGACCCGTGAG TCGGAGGCTGTCCGCGAGGCCGATGCCCGCACCGGCCGGACCTGGATCATCTCCAACCCC GAATCCAAGAACCGTCTCAACGAGCCGGTGGGCTACAAGCTGCACGCCCACAACCAGCCC ACCCTGCTGGCCGATCCCGGGTCCTCCATTGCGCGGCGGGCCGCCTTTGCCACCAAGGAC CTGTGGGTCACCCGCTACGCCGACGACGAGCGCTACCCCACCGGCGACTTCGTCAACCAG CACTCCGGCGGCGCGGGCCTGCCCTCCTACATCGCCCAGGACCGCGACATCGACGGCCAG GACATCGTCGTGTGGCACACCTTCGGACTGACCCACTTCCCGCGCGTGGAGGACTGGCCC ATCATGCCGGTGGACACCGTCGGCTTCAAGCTCCGTCCCGAGGGCTTCTTCGACCGCAGC CCGGTCCTCGATGTCCCGGCCAACCCCAGCCAGTCCGGCTCCCACTGCCACGGCTAG PF01179 Cu_amine_oxid PF02727 Cu_amine_oxidN2 PF02728 Cu_amine_oxidN3 function binding function ion binding function cation binding function transition metal ion binding function copper ion binding "
owl:sameAs	drug:EXPT03094

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt

The resource does not appear as an object

Context graph